Yeabsra Aleligne

ORCID: 0000-0003-3465-0768
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiovascular Function and Risk Factors
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Mast cells and histamine
  • Parathyroid Disorders and Treatments
  • Cardiac Valve Diseases and Treatments
  • Health Promotion and Cardiovascular Prevention
  • Pleural and Pulmonary Diseases
  • Pneumothorax, Barotrauma, Emphysema
  • Biotin and Related Studies
  • COVID-19 and Mental Health
  • Pulmonary Hypertension Research and Treatments
  • COVID-19 and healthcare impacts
  • Cardiomyopathy and Myosin Studies
  • Congenital Heart Disease Studies
  • Racial and Ethnic Identity Research
  • Cardiovascular Health and Risk Factors
  • Cardiac Health and Mental Health
  • Renin-Angiotensin System Studies
  • Industrial Vision Systems and Defect Detection

University of California, Davis
2021-2024

University of California Davis Medical Center
2023

University of California, Los Angeles
2019

UCLA Health
2018

New York Medical College
2016

Age-dependent alteration of the renin-angiotensin system (RAS) and generation angiotensin II (Ang II) are well documented. By contrast, RAS-independent Ang in aging its responses to exercise have not been explored. To this end, we examined effects chymase, a secretory serine protease, on angiotensin-converting enzyme (ACE)-independent conversion I II. We hypothesized that age-dependent cardiac formation is chymase dependent nature prevented by training. Experiments were conducted hearts...

10.1152/ajpheart.00534.2016 article EN AJP Heart and Circulatory Physiology 2016-11-05

Transthyretin amyloid cardiomyopathy (ATTR-CM) affects all cardiac chambers to cause left ventricular (LV) deformation as well atrial (LA) remodeling and functional impairment. We investigated the associations of LA volume index (LAVI):LV ejection fraction (LVEF) ratio with increased risk death, heart transplant, or LV assist device implantation (LVAD) in patients ATTR-CM.

10.3390/jcdd11110363 article EN cc-by Journal of Cardiovascular Development and Disease 2024-11-08

10.1016/s0735-1097(21)03316-7 article EN publisher-specific-oa Journal of the American College of Cardiology 2021-05-01

Introduction Angiotensin II (Ang II) is a key effector peptide of the renin angiotensin system (RAS) and primarily known to be metabolized by converting enzyme 1 (ACE 1) from I I). More recently, chymase, an endopeptidase present in mast cells, has been reported play large role conversion Ang II. While ACE chymase are involved production I, another RAS related enzyme, 2 2), degradation. The cumulative effect 1, may ultimately determine levels tissues. Although adequate necessary for proper...

10.1096/fasebj.30.1_supplement.lb599 article EN The FASEB Journal 2016-04-01

10.1016/s0735-1097(23)03407-1 article EN publisher-specific-oa Journal of the American College of Cardiology 2023-03-01
Coming Soon ...